HOME >> MEDICINE >> NEWS
Medical debt draining Kansans' resources, threatening health care access

A new report documents that many lower-income Kansans face unaffordable medical bills, resulting in overwhelming debt that severely impairs their financial stability.

The report, "Playing by the rules but losing: How medical debt threatens Kansans' healthcare access and financial security," was written by The Access Project, a national research and health advocacy organization, which will release the research results on February 2nd. A phone-in press conference will be held that day at 10:00 a.m. CST.

The Access Project has published widely on the subject of medical debt. Its Kansas research was funded through grants from the United Methodist Health Ministry Fund as part of its mission to help improve the health of Kansans, as well as the W. K. Kellogg Foundation.

According to Kim Moore, Health Fund president, the report reveals that medical debt is becoming commonplace in Kansas. Nearly two-thirds of the respondents in the study had medical debt, which affected people in every racial and ethnic group, and the insured as well as the uninsured.

The research found that people drew on whatever resources they had available to try to pay down their debt. "This report shows that Kansans are playing by the rules and trying to pay off their bills" Moore said, "but in spite of their struggle, they come up short. Something's wrong when so many people use up their hard-earned savings, borrow from friends, take out loans, and jeopardize their credit in order to pay off medical bills." The findings contradict the notion that many patients have the resources but simply refuse to pay for care.

The Access Project and its research partners at the Schneider Institute for Health Policy at Brandeis University worked with four community health centers in Kansas on the study. The researchers surveyed clients at the health centers located in Wichita, Garden City and Emporia -- gathering responses from over 1,000 participants. The survey
'"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
2-Feb-2006


Page: 1 2 3

Related medicine news :

1. Medical residents score poorly in diagnosing and managing tuberculosis
2. Medical residents unclear about TB guidelines
3. Medical students respond positively to simulated patient experience
4. Weill Cornell Medical College announces gifts totaling $400M
5. Medicalizing the human condition
6. Medical management of another condition may not lead to early cancer diagnosis
7. Elsevier partners with European Federation of Organizations for Medical Physics
8. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
9. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
10. Medical, high-energy physicists collaborate to improve PET scans
11. Medical students should be taught about rape

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: